Listed times are in Central European Time (CET)

WELCOME

Perspective on Prevention - Emmy Verschuren & Cathrin Brisken

Allan Balmain UC San Francisco, USA

" How can normal phenotypes be sustained despite cancer mutations?"

Q&A 13:30 - 13:40

Olivia Fletcher Institute of Cancer Research, UK

"Common genetic variants, hormones and breast cancer risk"

Q&A 14:00 - 14:10

Transition break

Rebecca Fitzgerald University of Cambridge, UK

"Earlier detection to pave the way for cancer prevention: lessons from the oesophagus"

Q&A 14:35 - 14:45

Break time for coffee & a stretch!

Susan Domchek University of Pennsylvania, USA

"Genomic medicine meets cancer interception: Lessons from BRCA"

Q&A 15:20-15:30

Transition break

David Mooney Wyss Institute at Harvard University, USA

"Biomaterials-based cancer vaccines"

Q&A 15:55 - 16:05

Transition break

DISCUSSION SESSION

Closing the gap: Putting prevention into action, and how can patients be involved?

Featuring all invited speakers, Cyrille Cohen, and for Patient perspectives: Azra Raza and Amanda McCann, Pharma-oriented perspectives: John Hickman and Larissa Carnevalli

CLOSING REMARKS